nodes	percent_of_prediction	percent_of_DWPC	metapath
Valproic Acid—UGT2B7—Epirubicin—ovarian cancer	0.111	0.306	CbGbCtD
Valproic Acid—SLC22A7—Docetaxel—ovarian cancer	0.0713	0.197	CbGbCtD
Valproic Acid—CYP3A5—Paclitaxel—ovarian cancer	0.0287	0.0794	CbGbCtD
Valproic Acid—CYP2C8—Paclitaxel—ovarian cancer	0.0276	0.0763	CbGbCtD
Valproic Acid—CYP3A4—Topotecan—ovarian cancer	0.0226	0.0625	CbGbCtD
Valproic Acid—CYP3A5—Docetaxel—ovarian cancer	0.0208	0.0574	CbGbCtD
Valproic Acid—CYP2B6—Doxorubicin—ovarian cancer	0.0196	0.0543	CbGbCtD
Valproic Acid—CYP2C9—Paclitaxel—ovarian cancer	0.0193	0.0532	CbGbCtD
Valproic Acid—CYP3A4—Vinorelbine—ovarian cancer	0.0159	0.0441	CbGbCtD
Valproic Acid—CYP3A4—Paclitaxel—ovarian cancer	0.0112	0.031	CbGbCtD
Valproic Acid—CYP3A4—Docetaxel—ovarian cancer	0.0081	0.0224	CbGbCtD
Valproic Acid—HDAC2—oviduct—ovarian cancer	0.00634	0.0408	CbGeAlD
Valproic Acid—CYP3A4—Doxorubicin—ovarian cancer	0.00603	0.0167	CbGbCtD
Valproic Acid—ALDH5A1—Vinblastine—Vinorelbine—ovarian cancer	0.00558	1	CbGdCrCtD
Valproic Acid—ACADSB—myometrium—ovarian cancer	0.00358	0.023	CbGeAlD
Valproic Acid—OGDH—uterine cervix—ovarian cancer	0.00351	0.0225	CbGeAlD
Valproic Acid—OGDH—decidua—ovarian cancer	0.00334	0.0215	CbGeAlD
Valproic Acid—HDAC9—uterine cervix—ovarian cancer	0.00309	0.0199	CbGeAlD
Valproic Acid—HDAC9—decidua—ovarian cancer	0.00294	0.0189	CbGeAlD
Valproic Acid—OGDH—gonad—ovarian cancer	0.00294	0.0189	CbGeAlD
Valproic Acid—OGDH—uterus—ovarian cancer	0.00292	0.0188	CbGeAlD
Valproic Acid—ACADSB—uterine cervix—ovarian cancer	0.00278	0.0179	CbGeAlD
Valproic Acid—UGT1A6—testis—ovarian cancer	0.00268	0.0172	CbGeAlD
Valproic Acid—ACADSB—decidua—ovarian cancer	0.00265	0.017	CbGeAlD
Valproic Acid—OGDH—female reproductive system—ovarian cancer	0.00263	0.0169	CbGeAlD
Valproic Acid—HDAC9—uterus—ovarian cancer	0.00258	0.0166	CbGeAlD
Valproic Acid—PTGS1—oviduct—ovarian cancer	0.00253	0.0163	CbGeAlD
Valproic Acid—ACADSB—endometrium—ovarian cancer	0.00252	0.0162	CbGeAlD
Valproic Acid—OGDH—bone marrow—ovarian cancer	0.00248	0.0159	CbGeAlD
Valproic Acid—ALDH5A1—uterine cervix—ovarian cancer	0.00245	0.0158	CbGeAlD
Valproic Acid—OGDH—female gonad—ovarian cancer	0.00239	0.0154	CbGeAlD
Valproic Acid—UGT2B15—female reproductive system—ovarian cancer	0.00237	0.0152	CbGeAlD
Valproic Acid—ALDH5A1—decidua—ovarian cancer	0.00234	0.015	CbGeAlD
Valproic Acid—ACADSB—uterus—ovarian cancer	0.00232	0.0149	CbGeAlD
Valproic Acid—HDAC9—female reproductive system—ovarian cancer	0.00232	0.0149	CbGeAlD
Valproic Acid—HDAC9—bone marrow—ovarian cancer	0.00219	0.014	CbGeAlD
Valproic Acid—OGDH—testis—ovarian cancer	0.00212	0.0136	CbGeAlD
Valproic Acid—HDAC9—female gonad—ovarian cancer	0.00211	0.0135	CbGeAlD
Valproic Acid—CYP2C18—uterine cervix—ovarian cancer	0.00209	0.0135	CbGeAlD
Valproic Acid—ACADSB—female reproductive system—ovarian cancer	0.00209	0.0134	CbGeAlD
Valproic Acid—ALDH5A1—gonad—ovarian cancer	0.00206	0.0132	CbGeAlD
Valproic Acid—ACADSB—bone marrow—ovarian cancer	0.00197	0.0127	CbGeAlD
Valproic Acid—HDAC2—embryo—ovarian cancer	0.00195	0.0125	CbGeAlD
Valproic Acid—ACADSB—female gonad—ovarian cancer	0.0019	0.0122	CbGeAlD
Valproic Acid—ACADSB—vagina—ovarian cancer	0.00189	0.0121	CbGeAlD
Valproic Acid—HDAC9—testis—ovarian cancer	0.00187	0.012	CbGeAlD
Valproic Acid—ALDH5A1—female reproductive system—ovarian cancer	0.00184	0.0118	CbGeAlD
Valproic Acid—ABAT—gonad—ovarian cancer	0.00176	0.0113	CbGeAlD
Valproic Acid—ALDH5A1—bone marrow—ovarian cancer	0.00173	0.0111	CbGeAlD
Valproic Acid—ACADSB—testis—ovarian cancer	0.00168	0.0108	CbGeAlD
Valproic Acid—ALDH5A1—female gonad—ovarian cancer	0.00167	0.0107	CbGeAlD
Valproic Acid—ALDH5A1—vagina—ovarian cancer	0.00166	0.0107	CbGeAlD
Valproic Acid—HDAC2—epithelium—ovarian cancer	0.00159	0.0102	CbGeAlD
Valproic Acid—HDAC2—uterine cervix—ovarian cancer	0.00158	0.0102	CbGeAlD
Valproic Acid—OGDH—lymph node—ovarian cancer	0.00154	0.00987	CbGeAlD
Valproic Acid—HDAC2—decidua—ovarian cancer	0.00151	0.00967	CbGeAlD
Valproic Acid—ALDH5A1—testis—ovarian cancer	0.00148	0.00953	CbGeAlD
Valproic Acid—UGT2B7—female reproductive system—ovarian cancer	0.00145	0.00929	CbGeAlD
Valproic Acid—ABAT—female gonad—ovarian cancer	0.00143	0.00919	CbGeAlD
Valproic Acid—HDAC2—endometrium—ovarian cancer	0.00143	0.00918	CbGeAlD
Valproic Acid—ABAT—vagina—ovarian cancer	0.00142	0.00913	CbGeAlD
Valproic Acid—CYP2C18—vagina—ovarian cancer	0.00142	0.00911	CbGeAlD
Valproic Acid—SLC16A1—epithelium—ovarian cancer	0.00142	0.0091	CbGeAlD
Valproic Acid—HDAC9—lymph node—ovarian cancer	0.00135	0.0087	CbGeAlD
Valproic Acid—SLC16A1—decidua—ovarian cancer	0.00134	0.0086	CbGeAlD
Valproic Acid—HDAC2—gonad—ovarian cancer	0.00133	0.00852	CbGeAlD
Valproic Acid—HDAC2—uterus—ovarian cancer	0.00132	0.00846	CbGeAlD
Valproic Acid—SLC16A1—endometrium—ovarian cancer	0.00127	0.00816	CbGeAlD
Valproic Acid—ABAT—testis—ovarian cancer	0.00127	0.00815	CbGeAlD
Valproic Acid—ACADSB—lymph node—ovarian cancer	0.00122	0.00784	CbGeAlD
Valproic Acid—HDAC2—female reproductive system—ovarian cancer	0.00118	0.00761	CbGeAlD
Valproic Acid—SLC16A1—gonad—ovarian cancer	0.00118	0.00757	CbGeAlD
Valproic Acid—SLC16A1—uterus—ovarian cancer	0.00117	0.00752	CbGeAlD
Valproic Acid—UGT2B7—testis—ovarian cancer	0.00117	0.0075	CbGeAlD
Valproic Acid—HDAC2—bone marrow—ovarian cancer	0.00112	0.00718	CbGeAlD
Valproic Acid—SLC22A7—testis—ovarian cancer	0.00111	0.00713	CbGeAlD
Valproic Acid—HDAC2—female gonad—ovarian cancer	0.00108	0.00692	CbGeAlD
Valproic Acid—ALDH5A1—lymph node—ovarian cancer	0.00107	0.00691	CbGeAlD
Valproic Acid—HDAC2—vagina—ovarian cancer	0.00107	0.00688	CbGeAlD
Valproic Acid—SLC16A1—female reproductive system—ovarian cancer	0.00105	0.00676	CbGeAlD
Valproic Acid—SLC22A5—myometrium—ovarian cancer	0.00103	0.00662	CbGeAlD
Valproic Acid—SLC16A1—female gonad—ovarian cancer	0.000957	0.00615	CbGeAlD
Valproic Acid—HDAC2—testis—ovarian cancer	0.000955	0.00614	CbGeAlD
Valproic Acid—CYP2A6—vagina—ovarian cancer	0.000937	0.00602	CbGeAlD
Valproic Acid—ABAT—lymph node—ovarian cancer	0.000919	0.00591	CbGeAlD
Valproic Acid—SLC16A1—testis—ovarian cancer	0.000849	0.00545	CbGeAlD
Valproic Acid—SLC22A5—uterine cervix—ovarian cancer	0.000802	0.00515	CbGeAlD
Valproic Acid—SLC22A5—endometrium—ovarian cancer	0.000725	0.00466	CbGeAlD
Valproic Acid—CYP2C8—endometrium—ovarian cancer	0.000702	0.00451	CbGeAlD
Valproic Acid—CYP3A5—uterine cervix—ovarian cancer	0.000701	0.0045	CbGeAlD
Valproic Acid—HDAC2—lymph node—ovarian cancer	0.000692	0.00445	CbGeAlD
Valproic Acid—PTGS1—epithelium—ovarian cancer	0.000635	0.00408	CbGeAlD
Valproic Acid—PTGS1—uterine cervix—ovarian cancer	0.00063	0.00405	CbGeAlD
Valproic Acid—SLC16A1—lymph node—ovarian cancer	0.000615	0.00395	CbGeAlD
Valproic Acid—CYP2C19—vagina—ovarian cancer	0.000603	0.00387	CbGeAlD
Valproic Acid—SLC22A5—female reproductive system—ovarian cancer	0.000601	0.00386	CbGeAlD
Valproic Acid—CYP2B6—gonad—ovarian cancer	0.000584	0.00376	CbGeAlD
Valproic Acid—CYP2C8—female reproductive system—ovarian cancer	0.000582	0.00374	CbGeAlD
Valproic Acid—PTGS1—endometrium—ovarian cancer	0.00057	0.00366	CbGeAlD
Valproic Acid—SLC22A5—female gonad—ovarian cancer	0.000547	0.00351	CbGeAlD
Valproic Acid—SLC22A5—vagina—ovarian cancer	0.000543	0.00349	CbGeAlD
Valproic Acid—CYP2C8—vagina—ovarian cancer	0.000526	0.00338	CbGeAlD
Valproic Acid—PTGS1—uterus—ovarian cancer	0.000525	0.00337	CbGeAlD
Valproic Acid—CYP2B6—female reproductive system—ovarian cancer	0.000522	0.00335	CbGeAlD
Valproic Acid—CYP2C9—female reproductive system—ovarian cancer	0.000517	0.00332	CbGeAlD
Valproic Acid—SLC22A5—testis—ovarian cancer	0.000485	0.00312	CbGeAlD
Valproic Acid—CYP3A5—female gonad—ovarian cancer	0.000478	0.00307	CbGeAlD
Valproic Acid—CYP3A5—vagina—ovarian cancer	0.000475	0.00305	CbGeAlD
Valproic Acid—CYP2B6—vagina—ovarian cancer	0.000472	0.00303	CbGeAlD
Valproic Acid—PTGS1—female reproductive system—ovarian cancer	0.000472	0.00303	CbGeAlD
Valproic Acid—CYP2C8—testis—ovarian cancer	0.00047	0.00302	CbGeAlD
Valproic Acid—PTGS1—female gonad—ovarian cancer	0.000429	0.00276	CbGeAlD
Valproic Acid—PTGS1—vagina—ovarian cancer	0.000427	0.00274	CbGeAlD
Valproic Acid—CYP2B6—testis—ovarian cancer	0.000421	0.00271	CbGeAlD
Valproic Acid—CYP3A4—female reproductive system—ovarian cancer	0.000394	0.00253	CbGeAlD
Valproic Acid—PTGS1—testis—ovarian cancer	0.000381	0.00245	CbGeAlD
Valproic Acid—SLC22A5—lymph node—ovarian cancer	0.000352	0.00226	CbGeAlD
Valproic Acid—PTGS1—lymph node—ovarian cancer	0.000276	0.00177	CbGeAlD
Valproic Acid—Arthralgia—Docetaxel—ovarian cancer	0.00016	0.000502	CcSEcCtD
Valproic Acid—Pancytopenia—Doxorubicin—ovarian cancer	0.00016	0.000502	CcSEcCtD
Valproic Acid—Nausea—Vinorelbine—ovarian cancer	0.00016	0.000502	CcSEcCtD
Valproic Acid—Dyspepsia—Paclitaxel—ovarian cancer	0.000159	0.0005	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000159	0.000499	CcSEcCtD
Valproic Acid—Stomatitis—Epirubicin—ovarian cancer	0.000158	0.000496	CcSEcCtD
Valproic Acid—Conjunctivitis—Epirubicin—ovarian cancer	0.000158	0.000495	CcSEcCtD
Valproic Acid—Urinary tract infection—Epirubicin—ovarian cancer	0.000158	0.000495	CcSEcCtD
Valproic Acid—Neutropenia—Doxorubicin—ovarian cancer	0.000157	0.000494	CcSEcCtD
Valproic Acid—Dysuria—Doxorubicin—ovarian cancer	0.000157	0.000494	CcSEcCtD
Valproic Acid—Decreased appetite—Paclitaxel—ovarian cancer	0.000157	0.000494	CcSEcCtD
Valproic Acid—Dry mouth—Docetaxel—ovarian cancer	0.000157	0.000491	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000156	0.00049	CcSEcCtD
Valproic Acid—Fatigue—Paclitaxel—ovarian cancer	0.000156	0.00049	CcSEcCtD
Valproic Acid—Sweating—Epirubicin—ovarian cancer	0.000156	0.000488	CcSEcCtD
Valproic Acid—Pollakiuria—Doxorubicin—ovarian cancer	0.000156	0.000488	CcSEcCtD
Valproic Acid—Constipation—Paclitaxel—ovarian cancer	0.000155	0.000486	CcSEcCtD
Valproic Acid—Pain—Paclitaxel—ovarian cancer	0.000155	0.000486	CcSEcCtD
Valproic Acid—Confusional state—Docetaxel—ovarian cancer	0.000155	0.000486	CcSEcCtD
Valproic Acid—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000154	0.000482	CcSEcCtD
Valproic Acid—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000153	0.000482	CcSEcCtD
Valproic Acid—Anaphylactic shock—Docetaxel—ovarian cancer	0.000153	0.000482	CcSEcCtD
Valproic Acid—Oedema—Docetaxel—ovarian cancer	0.000153	0.000482	CcSEcCtD
Valproic Acid—Weight increased—Doxorubicin—ovarian cancer	0.000153	0.000481	CcSEcCtD
Valproic Acid—Epistaxis—Epirubicin—ovarian cancer	0.000153	0.00048	CcSEcCtD
Valproic Acid—Infection—Docetaxel—ovarian cancer	0.000152	0.000478	CcSEcCtD
Valproic Acid—Weight decreased—Doxorubicin—ovarian cancer	0.000152	0.000478	CcSEcCtD
Valproic Acid—Sinusitis—Epirubicin—ovarian cancer	0.000152	0.000478	CcSEcCtD
Valproic Acid—Agranulocytosis—Epirubicin—ovarian cancer	0.000151	0.000475	CcSEcCtD
Valproic Acid—Pneumonia—Doxorubicin—ovarian cancer	0.000151	0.000474	CcSEcCtD
Valproic Acid—Nervous system disorder—Docetaxel—ovarian cancer	0.00015	0.000472	CcSEcCtD
Valproic Acid—Thrombocytopenia—Docetaxel—ovarian cancer	0.00015	0.000471	CcSEcCtD
Valproic Acid—Drowsiness—Doxorubicin—ovarian cancer	0.00015	0.000471	CcSEcCtD
Valproic Acid—Tachycardia—Docetaxel—ovarian cancer	0.00015	0.00047	CcSEcCtD
Valproic Acid—Feeling abnormal—Paclitaxel—ovarian cancer	0.000149	0.000468	CcSEcCtD
Valproic Acid—Skin disorder—Docetaxel—ovarian cancer	0.000149	0.000468	CcSEcCtD
Valproic Acid—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000149	0.000467	CcSEcCtD
Valproic Acid—Bradycardia—Epirubicin—ovarian cancer	0.000148	0.000465	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000148	0.000465	CcSEcCtD
Valproic Acid—Haemoglobin—Epirubicin—ovarian cancer	0.000146	0.000459	CcSEcCtD
Valproic Acid—Stomatitis—Doxorubicin—ovarian cancer	0.000146	0.000459	CcSEcCtD
Valproic Acid—Anorexia—Docetaxel—ovarian cancer	0.000146	0.000459	CcSEcCtD
Valproic Acid—Rhinitis—Epirubicin—ovarian cancer	0.000146	0.000458	CcSEcCtD
Valproic Acid—Conjunctivitis—Doxorubicin—ovarian cancer	0.000146	0.000458	CcSEcCtD
Valproic Acid—Urinary tract infection—Doxorubicin—ovarian cancer	0.000146	0.000458	CcSEcCtD
Valproic Acid—Haemorrhage—Epirubicin—ovarian cancer	0.000146	0.000457	CcSEcCtD
Valproic Acid—Hypoaesthesia—Epirubicin—ovarian cancer	0.000145	0.000455	CcSEcCtD
Valproic Acid—Pharyngitis—Epirubicin—ovarian cancer	0.000145	0.000454	CcSEcCtD
Valproic Acid—Sweating—Doxorubicin—ovarian cancer	0.000144	0.000452	CcSEcCtD
Valproic Acid—Urinary tract disorder—Epirubicin—ovarian cancer	0.000144	0.000451	CcSEcCtD
Valproic Acid—Urticaria—Paclitaxel—ovarian cancer	0.000144	0.000451	CcSEcCtD
Valproic Acid—Oedema peripheral—Epirubicin—ovarian cancer	0.000143	0.00045	CcSEcCtD
Valproic Acid—Hypotension—Docetaxel—ovarian cancer	0.000143	0.00045	CcSEcCtD
Valproic Acid—Connective tissue disorder—Epirubicin—ovarian cancer	0.000143	0.000449	CcSEcCtD
Valproic Acid—Abdominal pain—Paclitaxel—ovarian cancer	0.000143	0.000449	CcSEcCtD
Valproic Acid—Body temperature increased—Paclitaxel—ovarian cancer	0.000143	0.000449	CcSEcCtD
Valproic Acid—Urethral disorder—Epirubicin—ovarian cancer	0.000143	0.000448	CcSEcCtD
Valproic Acid—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000142	0.000446	CcSEcCtD
Valproic Acid—Epistaxis—Doxorubicin—ovarian cancer	0.000142	0.000444	CcSEcCtD
Valproic Acid—Sinusitis—Doxorubicin—ovarian cancer	0.000141	0.000442	CcSEcCtD
Valproic Acid—Visual impairment—Epirubicin—ovarian cancer	0.00014	0.000441	CcSEcCtD
Valproic Acid—Agranulocytosis—Doxorubicin—ovarian cancer	0.00014	0.00044	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.00014	0.000439	CcSEcCtD
Valproic Acid—Insomnia—Docetaxel—ovarian cancer	0.000139	0.000436	CcSEcCtD
Valproic Acid—Paraesthesia—Docetaxel—ovarian cancer	0.000138	0.000432	CcSEcCtD
Valproic Acid—Erythema multiforme—Epirubicin—ovarian cancer	0.000138	0.000432	CcSEcCtD
Valproic Acid—Bradycardia—Doxorubicin—ovarian cancer	0.000137	0.000431	CcSEcCtD
Valproic Acid—Dyspnoea—Docetaxel—ovarian cancer	0.000137	0.000429	CcSEcCtD
Valproic Acid—Somnolence—Docetaxel—ovarian cancer	0.000136	0.000428	CcSEcCtD
Valproic Acid—Eye disorder—Epirubicin—ovarian cancer	0.000136	0.000427	CcSEcCtD
Valproic Acid—Tinnitus—Epirubicin—ovarian cancer	0.000136	0.000426	CcSEcCtD
Valproic Acid—Haemoglobin—Doxorubicin—ovarian cancer	0.000135	0.000425	CcSEcCtD
Valproic Acid—Rhinitis—Doxorubicin—ovarian cancer	0.000135	0.000424	CcSEcCtD
Valproic Acid—Dyspepsia—Docetaxel—ovarian cancer	0.000135	0.000424	CcSEcCtD
Valproic Acid—Haemorrhage—Doxorubicin—ovarian cancer	0.000135	0.000423	CcSEcCtD
Valproic Acid—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000134	0.000421	CcSEcCtD
Valproic Acid—Pharyngitis—Doxorubicin—ovarian cancer	0.000134	0.00042	CcSEcCtD
Valproic Acid—Decreased appetite—Docetaxel—ovarian cancer	0.000133	0.000419	CcSEcCtD
Valproic Acid—Hypersensitivity—Paclitaxel—ovarian cancer	0.000133	0.000419	CcSEcCtD
Valproic Acid—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000133	0.000418	CcSEcCtD
Valproic Acid—Oedema peripheral—Doxorubicin—ovarian cancer	0.000133	0.000417	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000132	0.000416	CcSEcCtD
Valproic Acid—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000132	0.000416	CcSEcCtD
Valproic Acid—Fatigue—Docetaxel—ovarian cancer	0.000132	0.000415	CcSEcCtD
Valproic Acid—Angiopathy—Epirubicin—ovarian cancer	0.000132	0.000415	CcSEcCtD
Valproic Acid—Urethral disorder—Doxorubicin—ovarian cancer	0.000132	0.000415	CcSEcCtD
Valproic Acid—Immune system disorder—Epirubicin—ovarian cancer	0.000132	0.000413	CcSEcCtD
Valproic Acid—Mediastinal disorder—Epirubicin—ovarian cancer	0.000131	0.000412	CcSEcCtD
Valproic Acid—Pain—Docetaxel—ovarian cancer	0.000131	0.000412	CcSEcCtD
Valproic Acid—Constipation—Docetaxel—ovarian cancer	0.000131	0.000412	CcSEcCtD
Valproic Acid—Chills—Epirubicin—ovarian cancer	0.000131	0.00041	CcSEcCtD
Valproic Acid—Arrhythmia—Epirubicin—ovarian cancer	0.00013	0.000408	CcSEcCtD
Valproic Acid—Visual impairment—Doxorubicin—ovarian cancer	0.00013	0.000408	CcSEcCtD
Valproic Acid—Asthenia—Paclitaxel—ovarian cancer	0.00013	0.000408	CcSEcCtD
Valproic Acid—Alopecia—Epirubicin—ovarian cancer	0.000129	0.000404	CcSEcCtD
Valproic Acid—Pruritus—Paclitaxel—ovarian cancer	0.000128	0.000402	CcSEcCtD
Valproic Acid—Mental disorder—Epirubicin—ovarian cancer	0.000128	0.000401	CcSEcCtD
Valproic Acid—Erythema multiforme—Doxorubicin—ovarian cancer	0.000127	0.0004	CcSEcCtD
Valproic Acid—Malnutrition—Epirubicin—ovarian cancer	0.000127	0.000398	CcSEcCtD
Valproic Acid—Feeling abnormal—Docetaxel—ovarian cancer	0.000126	0.000397	CcSEcCtD
Valproic Acid—Eye disorder—Doxorubicin—ovarian cancer	0.000126	0.000395	CcSEcCtD
Valproic Acid—Tinnitus—Doxorubicin—ovarian cancer	0.000126	0.000394	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000125	0.000394	CcSEcCtD
Valproic Acid—Flatulence—Epirubicin—ovarian cancer	0.000125	0.000392	CcSEcCtD
Valproic Acid—Tension—Epirubicin—ovarian cancer	0.000124	0.000391	CcSEcCtD
Valproic Acid—Dysgeusia—Epirubicin—ovarian cancer	0.000124	0.00039	CcSEcCtD
Valproic Acid—Diarrhoea—Paclitaxel—ovarian cancer	0.000124	0.000389	CcSEcCtD
Valproic Acid—Nervousness—Epirubicin—ovarian cancer	0.000123	0.000387	CcSEcCtD
Valproic Acid—Back pain—Epirubicin—ovarian cancer	0.000123	0.000385	CcSEcCtD
Valproic Acid—Angiopathy—Doxorubicin—ovarian cancer	0.000122	0.000384	CcSEcCtD
Valproic Acid—Muscle spasms—Epirubicin—ovarian cancer	0.000122	0.000383	CcSEcCtD
Valproic Acid—Immune system disorder—Doxorubicin—ovarian cancer	0.000122	0.000382	CcSEcCtD
Valproic Acid—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000121	0.000381	CcSEcCtD
Valproic Acid—Body temperature increased—Docetaxel—ovarian cancer	0.000121	0.000381	CcSEcCtD
Valproic Acid—Abdominal pain—Docetaxel—ovarian cancer	0.000121	0.000381	CcSEcCtD
Valproic Acid—Chills—Doxorubicin—ovarian cancer	0.000121	0.00038	CcSEcCtD
Valproic Acid—Arrhythmia—Doxorubicin—ovarian cancer	0.00012	0.000378	CcSEcCtD
Valproic Acid—Dizziness—Paclitaxel—ovarian cancer	0.00012	0.000376	CcSEcCtD
Valproic Acid—Vision blurred—Epirubicin—ovarian cancer	0.00012	0.000375	CcSEcCtD
Valproic Acid—Alopecia—Doxorubicin—ovarian cancer	0.000119	0.000374	CcSEcCtD
Valproic Acid—Mental disorder—Doxorubicin—ovarian cancer	0.000118	0.000371	CcSEcCtD
Valproic Acid—Ill-defined disorder—Epirubicin—ovarian cancer	0.000118	0.000369	CcSEcCtD
Valproic Acid—Malnutrition—Doxorubicin—ovarian cancer	0.000117	0.000368	CcSEcCtD
Valproic Acid—Anaemia—Epirubicin—ovarian cancer	0.000117	0.000368	CcSEcCtD
Valproic Acid—Agitation—Epirubicin—ovarian cancer	0.000117	0.000366	CcSEcCtD
Valproic Acid—Flatulence—Doxorubicin—ovarian cancer	0.000116	0.000363	CcSEcCtD
Valproic Acid—Tension—Doxorubicin—ovarian cancer	0.000115	0.000361	CcSEcCtD
Valproic Acid—Vomiting—Paclitaxel—ovarian cancer	0.000115	0.000361	CcSEcCtD
Valproic Acid—Dysgeusia—Doxorubicin—ovarian cancer	0.000115	0.000361	CcSEcCtD
Valproic Acid—Malaise—Epirubicin—ovarian cancer	0.000114	0.000359	CcSEcCtD
Valproic Acid—Rash—Paclitaxel—ovarian cancer	0.000114	0.000358	CcSEcCtD
Valproic Acid—Dermatitis—Paclitaxel—ovarian cancer	0.000114	0.000358	CcSEcCtD
Valproic Acid—Nervousness—Doxorubicin—ovarian cancer	0.000114	0.000358	CcSEcCtD
Valproic Acid—Vertigo—Epirubicin—ovarian cancer	0.000114	0.000358	CcSEcCtD
Valproic Acid—Leukopenia—Epirubicin—ovarian cancer	0.000114	0.000356	CcSEcCtD
Valproic Acid—Back pain—Doxorubicin—ovarian cancer	0.000113	0.000356	CcSEcCtD
Valproic Acid—Headache—Paclitaxel—ovarian cancer	0.000113	0.000356	CcSEcCtD
Valproic Acid—Hypersensitivity—Docetaxel—ovarian cancer	0.000113	0.000355	CcSEcCtD
Valproic Acid—Muscle spasms—Doxorubicin—ovarian cancer	0.000113	0.000354	CcSEcCtD
Valproic Acid—Palpitations—Epirubicin—ovarian cancer	0.000112	0.000352	CcSEcCtD
Valproic Acid—Cough—Epirubicin—ovarian cancer	0.000111	0.000347	CcSEcCtD
Valproic Acid—Vision blurred—Doxorubicin—ovarian cancer	0.000111	0.000347	CcSEcCtD
Valproic Acid—Asthenia—Docetaxel—ovarian cancer	0.00011	0.000345	CcSEcCtD
Valproic Acid—Hypertension—Epirubicin—ovarian cancer	0.000109	0.000344	CcSEcCtD
Valproic Acid—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000109	0.000342	CcSEcCtD
Valproic Acid—Pruritus—Docetaxel—ovarian cancer	0.000109	0.000341	CcSEcCtD
Valproic Acid—Anaemia—Doxorubicin—ovarian cancer	0.000108	0.00034	CcSEcCtD
Valproic Acid—Myalgia—Epirubicin—ovarian cancer	0.000108	0.000339	CcSEcCtD
Valproic Acid—Chest pain—Epirubicin—ovarian cancer	0.000108	0.000339	CcSEcCtD
Valproic Acid—Arthralgia—Epirubicin—ovarian cancer	0.000108	0.000339	CcSEcCtD
Valproic Acid—Agitation—Doxorubicin—ovarian cancer	0.000108	0.000338	CcSEcCtD
Valproic Acid—Anxiety—Epirubicin—ovarian cancer	0.000108	0.000338	CcSEcCtD
Valproic Acid—Nausea—Paclitaxel—ovarian cancer	0.000108	0.000337	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000107	0.000336	CcSEcCtD
Valproic Acid—Discomfort—Epirubicin—ovarian cancer	0.000107	0.000335	CcSEcCtD
Valproic Acid—Malaise—Doxorubicin—ovarian cancer	0.000106	0.000332	CcSEcCtD
Valproic Acid—Dry mouth—Epirubicin—ovarian cancer	0.000106	0.000331	CcSEcCtD
Valproic Acid—Vertigo—Doxorubicin—ovarian cancer	0.000105	0.000331	CcSEcCtD
Valproic Acid—Leukopenia—Doxorubicin—ovarian cancer	0.000105	0.00033	CcSEcCtD
Valproic Acid—Diarrhoea—Docetaxel—ovarian cancer	0.000105	0.000329	CcSEcCtD
Valproic Acid—Confusional state—Epirubicin—ovarian cancer	0.000104	0.000327	CcSEcCtD
Valproic Acid—Palpitations—Doxorubicin—ovarian cancer	0.000104	0.000325	CcSEcCtD
Valproic Acid—Anaphylactic shock—Epirubicin—ovarian cancer	0.000103	0.000325	CcSEcCtD
Valproic Acid—Oedema—Epirubicin—ovarian cancer	0.000103	0.000325	CcSEcCtD
Valproic Acid—Infection—Epirubicin—ovarian cancer	0.000103	0.000323	CcSEcCtD
Valproic Acid—Cough—Doxorubicin—ovarian cancer	0.000102	0.000321	CcSEcCtD
Valproic Acid—Nervous system disorder—Epirubicin—ovarian cancer	0.000101	0.000319	CcSEcCtD
Valproic Acid—Dizziness—Docetaxel—ovarian cancer	0.000101	0.000318	CcSEcCtD
Valproic Acid—Thrombocytopenia—Epirubicin—ovarian cancer	0.000101	0.000318	CcSEcCtD
Valproic Acid—Hypertension—Doxorubicin—ovarian cancer	0.000101	0.000318	CcSEcCtD
Valproic Acid—Tachycardia—Epirubicin—ovarian cancer	0.000101	0.000317	CcSEcCtD
Valproic Acid—Skin disorder—Epirubicin—ovarian cancer	0.000101	0.000315	CcSEcCtD
Valproic Acid—Hyperhidrosis—Epirubicin—ovarian cancer	0.0001	0.000314	CcSEcCtD
Valproic Acid—Myalgia—Doxorubicin—ovarian cancer	9.99e-05	0.000313	CcSEcCtD
Valproic Acid—Arthralgia—Doxorubicin—ovarian cancer	9.99e-05	0.000313	CcSEcCtD
Valproic Acid—Chest pain—Doxorubicin—ovarian cancer	9.99e-05	0.000313	CcSEcCtD
Valproic Acid—Anxiety—Doxorubicin—ovarian cancer	9.95e-05	0.000312	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	9.92e-05	0.000311	CcSEcCtD
Valproic Acid—Discomfort—Doxorubicin—ovarian cancer	9.87e-05	0.00031	CcSEcCtD
Valproic Acid—Anorexia—Epirubicin—ovarian cancer	9.86e-05	0.00031	CcSEcCtD
Valproic Acid—Dry mouth—Doxorubicin—ovarian cancer	9.77e-05	0.000307	CcSEcCtD
Valproic Acid—Vomiting—Docetaxel—ovarian cancer	9.76e-05	0.000306	CcSEcCtD
Valproic Acid—Rash—Docetaxel—ovarian cancer	9.67e-05	0.000304	CcSEcCtD
Valproic Acid—Hypotension—Epirubicin—ovarian cancer	9.67e-05	0.000303	CcSEcCtD
Valproic Acid—Dermatitis—Docetaxel—ovarian cancer	9.67e-05	0.000303	CcSEcCtD
Valproic Acid—Confusional state—Doxorubicin—ovarian cancer	9.66e-05	0.000303	CcSEcCtD
Valproic Acid—Headache—Docetaxel—ovarian cancer	9.61e-05	0.000302	CcSEcCtD
Valproic Acid—Oedema—Doxorubicin—ovarian cancer	9.58e-05	0.000301	CcSEcCtD
Valproic Acid—Anaphylactic shock—Doxorubicin—ovarian cancer	9.58e-05	0.000301	CcSEcCtD
Valproic Acid—Infection—Doxorubicin—ovarian cancer	9.51e-05	0.000299	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Epirubicin—ovarian cancer	9.43e-05	0.000296	CcSEcCtD
Valproic Acid—Nervous system disorder—Doxorubicin—ovarian cancer	9.39e-05	0.000295	CcSEcCtD
Valproic Acid—Thrombocytopenia—Doxorubicin—ovarian cancer	9.38e-05	0.000294	CcSEcCtD
Valproic Acid—Insomnia—Epirubicin—ovarian cancer	9.36e-05	0.000294	CcSEcCtD
Valproic Acid—Tachycardia—Doxorubicin—ovarian cancer	9.35e-05	0.000293	CcSEcCtD
Valproic Acid—Skin disorder—Doxorubicin—ovarian cancer	9.3e-05	0.000292	CcSEcCtD
Valproic Acid—Paraesthesia—Epirubicin—ovarian cancer	9.29e-05	0.000292	CcSEcCtD
Valproic Acid—Hyperhidrosis—Doxorubicin—ovarian cancer	9.26e-05	0.000291	CcSEcCtD
Valproic Acid—Dyspnoea—Epirubicin—ovarian cancer	9.23e-05	0.00029	CcSEcCtD
Valproic Acid—Somnolence—Epirubicin—ovarian cancer	9.2e-05	0.000289	CcSEcCtD
Valproic Acid—Anorexia—Doxorubicin—ovarian cancer	9.13e-05	0.000286	CcSEcCtD
Valproic Acid—Nausea—Docetaxel—ovarian cancer	9.11e-05	0.000286	CcSEcCtD
Valproic Acid—Dyspepsia—Epirubicin—ovarian cancer	9.11e-05	0.000286	CcSEcCtD
Valproic Acid—Decreased appetite—Epirubicin—ovarian cancer	9e-05	0.000282	CcSEcCtD
Valproic Acid—Hypotension—Doxorubicin—ovarian cancer	8.95e-05	0.000281	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Epirubicin—ovarian cancer	8.93e-05	0.00028	CcSEcCtD
Valproic Acid—Fatigue—Epirubicin—ovarian cancer	8.92e-05	0.00028	CcSEcCtD
Valproic Acid—Pain—Epirubicin—ovarian cancer	8.85e-05	0.000278	CcSEcCtD
Valproic Acid—Constipation—Epirubicin—ovarian cancer	8.85e-05	0.000278	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	8.72e-05	0.000274	CcSEcCtD
Valproic Acid—Insomnia—Doxorubicin—ovarian cancer	8.66e-05	0.000272	CcSEcCtD
Valproic Acid—Paraesthesia—Doxorubicin—ovarian cancer	8.6e-05	0.00027	CcSEcCtD
Valproic Acid—Dyspnoea—Doxorubicin—ovarian cancer	8.54e-05	0.000268	CcSEcCtD
Valproic Acid—Feeling abnormal—Epirubicin—ovarian cancer	8.53e-05	0.000268	CcSEcCtD
Valproic Acid—Somnolence—Doxorubicin—ovarian cancer	8.51e-05	0.000267	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Epirubicin—ovarian cancer	8.46e-05	0.000266	CcSEcCtD
Valproic Acid—Dyspepsia—Doxorubicin—ovarian cancer	8.43e-05	0.000265	CcSEcCtD
Valproic Acid—Decreased appetite—Doxorubicin—ovarian cancer	8.32e-05	0.000261	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Doxorubicin—ovarian cancer	8.27e-05	0.000259	CcSEcCtD
Valproic Acid—Fatigue—Doxorubicin—ovarian cancer	8.26e-05	0.000259	CcSEcCtD
Valproic Acid—Urticaria—Epirubicin—ovarian cancer	8.22e-05	0.000258	CcSEcCtD
Valproic Acid—Pain—Doxorubicin—ovarian cancer	8.19e-05	0.000257	CcSEcCtD
Valproic Acid—Constipation—Doxorubicin—ovarian cancer	8.19e-05	0.000257	CcSEcCtD
Valproic Acid—Abdominal pain—Epirubicin—ovarian cancer	8.18e-05	0.000257	CcSEcCtD
Valproic Acid—Body temperature increased—Epirubicin—ovarian cancer	8.18e-05	0.000257	CcSEcCtD
Valproic Acid—Feeling abnormal—Doxorubicin—ovarian cancer	7.89e-05	0.000248	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Doxorubicin—ovarian cancer	7.83e-05	0.000246	CcSEcCtD
Valproic Acid—Hypersensitivity—Epirubicin—ovarian cancer	7.62e-05	0.000239	CcSEcCtD
Valproic Acid—Urticaria—Doxorubicin—ovarian cancer	7.61e-05	0.000239	CcSEcCtD
Valproic Acid—Body temperature increased—Doxorubicin—ovarian cancer	7.57e-05	0.000238	CcSEcCtD
Valproic Acid—Abdominal pain—Doxorubicin—ovarian cancer	7.57e-05	0.000238	CcSEcCtD
Valproic Acid—Asthenia—Epirubicin—ovarian cancer	7.43e-05	0.000233	CcSEcCtD
Valproic Acid—Pruritus—Epirubicin—ovarian cancer	7.32e-05	0.00023	CcSEcCtD
Valproic Acid—Diarrhoea—Epirubicin—ovarian cancer	7.08e-05	0.000222	CcSEcCtD
Valproic Acid—Hypersensitivity—Doxorubicin—ovarian cancer	7.05e-05	0.000221	CcSEcCtD
Valproic Acid—Asthenia—Doxorubicin—ovarian cancer	6.87e-05	0.000216	CcSEcCtD
Valproic Acid—Dizziness—Epirubicin—ovarian cancer	6.84e-05	0.000215	CcSEcCtD
Valproic Acid—Pruritus—Doxorubicin—ovarian cancer	6.77e-05	0.000213	CcSEcCtD
Valproic Acid—Vomiting—Epirubicin—ovarian cancer	6.58e-05	0.000207	CcSEcCtD
Valproic Acid—Diarrhoea—Doxorubicin—ovarian cancer	6.55e-05	0.000206	CcSEcCtD
Valproic Acid—Rash—Epirubicin—ovarian cancer	6.53e-05	0.000205	CcSEcCtD
Valproic Acid—Dermatitis—Epirubicin—ovarian cancer	6.52e-05	0.000205	CcSEcCtD
Valproic Acid—Headache—Epirubicin—ovarian cancer	6.48e-05	0.000203	CcSEcCtD
Valproic Acid—Dizziness—Doxorubicin—ovarian cancer	6.33e-05	0.000199	CcSEcCtD
Valproic Acid—Nausea—Epirubicin—ovarian cancer	6.15e-05	0.000193	CcSEcCtD
Valproic Acid—Vomiting—Doxorubicin—ovarian cancer	6.09e-05	0.000191	CcSEcCtD
Valproic Acid—Rash—Doxorubicin—ovarian cancer	6.04e-05	0.000189	CcSEcCtD
Valproic Acid—Dermatitis—Doxorubicin—ovarian cancer	6.03e-05	0.000189	CcSEcCtD
Valproic Acid—Headache—Doxorubicin—ovarian cancer	6e-05	0.000188	CcSEcCtD
Valproic Acid—Nausea—Doxorubicin—ovarian cancer	5.69e-05	0.000179	CcSEcCtD
Valproic Acid—UGT2B7—Metabolism—CAV1—ovarian cancer	1.78e-05	0.000113	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—AKT1—ovarian cancer	1.76e-05	0.000111	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—PIK3CB—ovarian cancer	1.76e-05	0.000111	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—ERBB2—ovarian cancer	1.74e-05	0.00011	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CAV1—ovarian cancer	1.72e-05	0.000109	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—PIK3CB—ovarian cancer	1.72e-05	0.000108	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—MTOR—ovarian cancer	1.72e-05	0.000108	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—CYP1B1—ovarian cancer	1.72e-05	0.000108	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.71e-05	0.000108	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—PIK3CA—ovarian cancer	1.69e-05	0.000107	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—PIK3CD—ovarian cancer	1.68e-05	0.000106	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PIK3CG—ovarian cancer	1.67e-05	0.000105	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—PIK3CA—ovarian cancer	1.67e-05	0.000105	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—ESR1—ovarian cancer	1.66e-05	0.000105	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PPP1CC—ovarian cancer	1.64e-05	0.000103	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—BRIP1—ovarian cancer	1.64e-05	0.000103	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—TP53—ovarian cancer	1.63e-05	0.000103	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—IL6ST—ovarian cancer	1.63e-05	0.000103	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PIK3CG—ovarian cancer	1.63e-05	0.000103	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—CDKN1B—ovarian cancer	1.61e-05	0.000102	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PPP2R1A—ovarian cancer	1.61e-05	0.000102	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.6e-05	0.000101	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—YAP1—ovarian cancer	1.58e-05	9.96e-05	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—PIK3CB—ovarian cancer	1.57e-05	9.91e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—APC—ovarian cancer	1.57e-05	9.9e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PIK3CG—ovarian cancer	1.57e-05	9.9e-05	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—HRAS—ovarian cancer	1.56e-05	9.86e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.56e-05	9.86e-05	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—AKT1—ovarian cancer	1.56e-05	9.83e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.53e-05	9.66e-05	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—PTEN—ovarian cancer	1.52e-05	9.61e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PPP2R1A—ovarian cancer	1.52e-05	9.6e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—CTNNB1—ovarian cancer	1.52e-05	9.6e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—FASN—ovarian cancer	1.52e-05	9.59e-05	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—IL6—ovarian cancer	1.5e-05	9.44e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—SLC5A5—ovarian cancer	1.49e-05	9.43e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—ABCB1—ovarian cancer	1.49e-05	9.43e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—FASN—ovarian cancer	1.49e-05	9.38e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—PTEN—ovarian cancer	1.48e-05	9.36e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PIK3CD—ovarian cancer	1.47e-05	9.27e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—TYMS—ovarian cancer	1.47e-05	9.26e-05	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—PIK3CB—ovarian cancer	1.47e-05	9.25e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—SLC5A5—ovarian cancer	1.46e-05	9.22e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—CAV1—ovarian cancer	1.45e-05	9.15e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CYTB—ovarian cancer	1.45e-05	9.12e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—SLC2A1—ovarian cancer	1.44e-05	9.11e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PIK3CD—ovarian cancer	1.43e-05	9.02e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—ABCB1—ovarian cancer	1.41e-05	8.92e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—SLC2A1—ovarian cancer	1.41e-05	8.91e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—YAP1—ovarian cancer	1.41e-05	8.89e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.4e-05	8.81e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.39e-05	8.8e-05	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—PIK3CA—ovarian cancer	1.39e-05	8.78e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—TYMS—ovarian cancer	1.39e-05	8.76e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.39e-05	8.75e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—CYP1B1—ovarian cancer	1.38e-05	8.74e-05	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—AKT1—ovarian cancer	1.38e-05	8.71e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PIK3CD—ovarian cancer	1.38e-05	8.7e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.37e-05	8.67e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—MAPK3—ovarian cancer	1.36e-05	8.61e-05	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—AKT1—ovarian cancer	1.36e-05	8.6e-05	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—PTEN—ovarian cancer	1.36e-05	8.57e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—CYP1B1—ovarian cancer	1.35e-05	8.54e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—MYC—ovarian cancer	1.33e-05	8.37e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—STAT3—ovarian cancer	1.33e-05	8.37e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—NRAS—ovarian cancer	1.32e-05	8.35e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PIK3CG—ovarian cancer	1.32e-05	8.34e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—FASN—ovarian cancer	1.29e-05	8.12e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—YAP1—ovarian cancer	1.28e-05	8.11e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PIK3CB—ovarian cancer	1.28e-05	8.08e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.27e-05	8.02e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—MAPK3—ovarian cancer	1.27e-05	7.99e-05	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—PTEN—ovarian cancer	1.27e-05	7.99e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—SLC5A5—ovarian cancer	1.27e-05	7.99e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PPP1CC—ovarian cancer	1.26e-05	7.97e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—BRIP1—ovarian cancer	1.26e-05	7.97e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PIK3CB—ovarian cancer	1.25e-05	7.86e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—MYC—ovarian cancer	1.23e-05	7.78e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PPP2R1A—ovarian cancer	1.23e-05	7.75e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.23e-05	7.74e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—SLC2A1—ovarian cancer	1.22e-05	7.71e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—ERBB2—ovarian cancer	1.22e-05	7.68e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—MAPK1—ovarian cancer	1.21e-05	7.61e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—EGFR—ovarian cancer	1.2e-05	7.61e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MTOR—ovarian cancer	1.2e-05	7.58e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PIK3CB—ovarian cancer	1.2e-05	7.58e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PPP2R1A—ovarian cancer	1.2e-05	7.57e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.2e-05	7.55e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.19e-05	7.53e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—CAV1—ovarian cancer	1.18e-05	7.46e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CYP1B1—ovarian cancer	1.17e-05	7.4e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PIK3CD—ovarian cancer	1.16e-05	7.33e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CXCL8—ovarian cancer	1.15e-05	7.29e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—FASN—ovarian cancer	1.15e-05	7.25e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—ABCB1—ovarian cancer	1.14e-05	7.19e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—KRAS—ovarian cancer	1.14e-05	7.18e-05	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—AKT1—ovarian cancer	1.14e-05	7.17e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—SLC5A5—ovarian cancer	1.13e-05	7.13e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.13e-05	7.13e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CDKN1B—ovarian cancer	1.13e-05	7.12e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—TYMS—ovarian cancer	1.12e-05	7.07e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—CAV1—ovarian cancer	1.12e-05	7.06e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.12e-05	7.05e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—ABCB1—ovarian cancer	1.11e-05	7.03e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PTEN—ovarian cancer	1.11e-05	6.98e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CASP3—ovarian cancer	1.1e-05	6.97e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—IL2—ovarian cancer	1.1e-05	6.96e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—YAP1—ovarian cancer	1.1e-05	6.93e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—TYMS—ovarian cancer	1.09e-05	6.91e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—SLC2A1—ovarian cancer	1.09e-05	6.89e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.09e-05	6.86e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PIK3CG—ovarian cancer	1.08e-05	6.8e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PTEN—ovarian cancer	1.08e-05	6.79e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CCND1—ovarian cancer	1.08e-05	6.79e-05	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—PIK3CA—ovarian cancer	1.07e-05	6.78e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.07e-05	6.74e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CTNNB1—ovarian cancer	1.07e-05	6.72e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—FASN—ovarian cancer	1.05e-05	6.61e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CYP1B1—ovarian cancer	1.05e-05	6.6e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—PIK3CA—ovarian cancer	1.05e-05	6.6e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MMP9—ovarian cancer	1.04e-05	6.59e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	1.04e-05	6.56e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PTEN—ovarian cancer	1.04e-05	6.55e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.03e-05	6.53e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—SLC5A5—ovarian cancer	1.03e-05	6.5e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PIK3CG—ovarian cancer	1.02e-05	6.43e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PIK3CB—ovarian cancer	1.01e-05	6.39e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—SLC2A1—ovarian cancer	9.95e-06	6.28e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	9.74e-06	6.15e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—HRAS—ovarian cancer	9.68e-06	6.11e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—ABCB1—ovarian cancer	9.65e-06	6.09e-05	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—PIK3CA—ovarian cancer	9.58e-06	6.04e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	9.55e-06	6.03e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CYP1B1—ovarian cancer	9.54e-06	6.02e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—TYMS—ovarian cancer	9.48e-06	5.98e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PIK3CD—ovarian cancer	9.47e-06	5.98e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—VEGFA—ovarian cancer	9.38e-06	5.92e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—STAT3—ovarian cancer	9.28e-06	5.86e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	9.28e-06	5.85e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—NRAS—ovarian cancer	9.26e-06	5.85e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—IL6—ovarian cancer	9.26e-06	5.84e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	9.23e-06	5.83e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—AKT1—ovarian cancer	9.2e-06	5.81e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—CAV1—ovarian cancer	9.02e-06	5.69e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PIK3CD—ovarian cancer	8.95e-06	5.65e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—FASN—ovarian cancer	8.95e-06	5.65e-05	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—PIK3CA—ovarian cancer	8.93e-06	5.64e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MAPK3—ovarian cancer	8.87e-06	5.6e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—CAV1—ovarian cancer	8.82e-06	5.56e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—SLC5A5—ovarian cancer	8.8e-06	5.56e-05	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—AKT1—ovarian cancer	8.78e-06	5.54e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PTEN—ovarian cancer	8.75e-06	5.52e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MYC—ovarian cancer	8.63e-06	5.44e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—ABCB1—ovarian cancer	8.61e-06	5.44e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—AKT1—ovarian cancer	8.54e-06	5.39e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—SLC2A1—ovarian cancer	8.5e-06	5.37e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—YAP1—ovarian cancer	8.47e-06	5.35e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—TYMS—ovarian cancer	8.46e-06	5.34e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	8.46e-06	5.34e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MAPK1—ovarian cancer	8.44e-06	5.33e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—EGFR—ovarian cancer	8.44e-06	5.33e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	8.42e-06	5.31e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	8.32e-06	5.25e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PIK3CB—ovarian cancer	8.25e-06	5.21e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PIK3CG—ovarian cancer	8.22e-06	5.19e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CYP1B1—ovarian cancer	8.15e-06	5.14e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PIK3CG—ovarian cancer	8.03e-06	5.07e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—KRAS—ovarian cancer	7.97e-06	5.03e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—ABCB1—ovarian cancer	7.85e-06	4.96e-05	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—AKT1—ovarian cancer	7.82e-06	4.94e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PIK3CA—ovarian cancer	7.81e-06	4.93e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PIK3CB—ovarian cancer	7.8e-06	4.92e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—TYMS—ovarian cancer	7.71e-06	4.87e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CAV1—ovarian cancer	7.64e-06	4.82e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PIK3CA—ovarian cancer	7.59e-06	4.79e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PIK3CA—ovarian cancer	7.32e-06	4.62e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	7.3e-06	4.6e-05	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—AKT1—ovarian cancer	7.3e-06	4.6e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	7.23e-06	4.56e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PIK3CD—ovarian cancer	7.22e-06	4.56e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	7.19e-06	4.54e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PTEN—ovarian cancer	7.13e-06	4.5e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TP53—ovarian cancer	7.08e-06	4.47e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PIK3CD—ovarian cancer	7.06e-06	4.46e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PIK3CG—ovarian cancer	6.96e-06	4.39e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—FASN—ovarian cancer	6.91e-06	4.36e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CAV1—ovarian cancer	6.82e-06	4.3e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—SLC5A5—ovarian cancer	6.79e-06	4.29e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—HRAS—ovarian cancer	6.78e-06	4.28e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PTEN—ovarian cancer	6.74e-06	4.26e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ABCB1—ovarian cancer	6.71e-06	4.24e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—TYMS—ovarian cancer	6.59e-06	4.16e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—SLC2A1—ovarian cancer	6.56e-06	4.14e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	6.51e-06	4.11e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—IL6—ovarian cancer	6.48e-06	4.09e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—AKT1—ovarian cancer	6.38e-06	4.02e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PIK3CB—ovarian cancer	6.3e-06	3.97e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CYP1B1—ovarian cancer	6.29e-06	3.97e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CAV1—ovarian cancer	6.22e-06	3.92e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PIK3CG—ovarian cancer	6.21e-06	3.92e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—AKT1—ovarian cancer	6.2e-06	3.92e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PIK3CA—ovarian cancer	6.17e-06	3.89e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PIK3CB—ovarian cancer	6.15e-06	3.88e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PIK3CD—ovarian cancer	6.12e-06	3.86e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—AKT1—ovarian cancer	5.98e-06	3.78e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.94e-06	3.75e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PIK3CG—ovarian cancer	5.66e-06	3.57e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	5.58e-06	3.52e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PIK3CD—ovarian cancer	5.46e-06	3.44e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PTEN—ovarian cancer	5.44e-06	3.43e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PIK3CB—ovarian cancer	5.33e-06	3.36e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PTEN—ovarian cancer	5.32e-06	3.36e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CAV1—ovarian cancer	5.31e-06	3.35e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ABCB1—ovarian cancer	5.18e-06	3.27e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—TYMS—ovarian cancer	5.09e-06	3.21e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.07e-06	3.2e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—AKT1—ovarian cancer	5.04e-06	3.18e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PIK3CA—ovarian cancer	5.03e-06	3.17e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PIK3CD—ovarian cancer	4.98e-06	3.14e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PIK3CG—ovarian cancer	4.84e-06	3.05e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PIK3CB—ovarian cancer	4.76e-06	3e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PIK3CA—ovarian cancer	4.76e-06	3e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PTEN—ovarian cancer	4.61e-06	2.91e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PIK3CB—ovarian cancer	4.34e-06	2.74e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PIK3CD—ovarian cancer	4.25e-06	2.68e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PTEN—ovarian cancer	4.11e-06	2.59e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—AKT1—ovarian cancer	4.11e-06	2.59e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CAV1—ovarian cancer	4.1e-06	2.59e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—AKT1—ovarian cancer	3.89e-06	2.45e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PIK3CA—ovarian cancer	3.84e-06	2.42e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PIK3CA—ovarian cancer	3.75e-06	2.37e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PTEN—ovarian cancer	3.75e-06	2.37e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PIK3CG—ovarian cancer	3.73e-06	2.36e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PIK3CB—ovarian cancer	3.71e-06	2.34e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PIK3CD—ovarian cancer	3.28e-06	2.07e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PIK3CA—ovarian cancer	3.25e-06	2.05e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PTEN—ovarian cancer	3.2e-06	2.02e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—AKT1—ovarian cancer	3.14e-06	1.98e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—AKT1—ovarian cancer	3.06e-06	1.93e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PIK3CA—ovarian cancer	2.9e-06	1.83e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PIK3CB—ovarian cancer	2.86e-06	1.81e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—AKT1—ovarian cancer	2.65e-06	1.68e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PIK3CA—ovarian cancer	2.64e-06	1.67e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PTEN—ovarian cancer	2.47e-06	1.56e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—AKT1—ovarian cancer	2.37e-06	1.5e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PIK3CA—ovarian cancer	2.26e-06	1.43e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—AKT1—ovarian cancer	2.16e-06	1.36e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—AKT1—ovarian cancer	1.85e-06	1.17e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.74e-06	1.1e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—AKT1—ovarian cancer	1.42e-06	8.99e-06	CbGpPWpGaD
